Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Perfluorohexyloctane · Miebo, NOV-03

Other · developed by Bausch And Lomb

Approved FDA, May 2023

BHC Developer

4 Registered trials

What is Perfluorohexyloctane?

Perfluorohexyloctane is a semifluorinated alkane ophthalmic solution that forms a monolayer at the air-liquid interface of the tear film to reduce tear evaporation.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: Miebo, NOV-03, Miebo four times per day
Drug type: Other
Therapy area: Ophthalmology
Developer: Bausch And Lomb Inc (BHC)
FDA status: Approved as Miebo (May 18, 2023), NDA216675 · FDA label
UNII: 7VYX4ELWQM

✅ FDA-approved uses

Dry eye disease

From the indications section of the FDA label (version of Mar 10, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT07650708	Phase 4	Dry Eye Syndrome (DES)	Recruiting	BHC
NCT07054606	Phase 4	Dry Eye	Completed	BHC
NCT06346340	Phase 4	Dry Eye	Completed	BHC
NCT07128628	Phase 2	Dry Eye Disease	Completed	BHC

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Dry Eye Disease (DED)Dry Eye Syndrome (DES)Dry EyeDry Eye Disease

More from Bausch And Lomb

Adapalene / Benzoyl Peroxide / Clindamycin FDA approved Brodalumab FDA approved Bupropion FDA approved Halobetasol Propionate And Tazarotene FDA approved IDP-118 FDA approved IDP-126 FDA approved Lifitegrast FDA approved Plecanatide FDA approved Rifaximin FDA approved Timolol FDA approved BL1107 Phase 2 BL1332 Phase 2

Sources

Updated Oct 3, 2026. Something wrong or missing? Report it on the BHC page.

Follow BHC, the company behind Perfluorohexyloctane

See BHC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

BHC catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z